Última actualização :
03/05/2024
Droga contra o câncer   Docetaxel  
Injetável
Estabilidade em soluções simples Estabilidade em misturas Factores que afectam a sua estabilidade Compatibilidade Método de administração Bibliografía Pdf
   Estrutura química  

Nomes comerciais nos diversos países   Nomes comerciais nos diversos países     

OS NOMES COMERCIAIS SÃO INDICATIVOS E OS EXCIPIENTES DA FORMULAÇÃO PODEM SER DIFERENTES CONFORME O PAÍS E FABRICANTE.

Adenex Colômbia
Asodocel Argentina
Axogen Chilli
Bagotaxel Chilli
Bendadocel Alemanha
Brecasta Chilli
Celtere Peru
Daxotel Chilli, Colômbia, Egipto, Malásia
Doce NC Alemanha
Docefrez Estados Unidos de América, Índia
Docekebir Argentina
Docetax Irã, Venezuela
Docetaxin Alemanha
Docewin Marrocos
Dolectran Argentina
Donataxel Argentina, Equator, Peru
Doxel Turquia, Venezuela
Doxetal Argentina
Doxitax Turquia
Oncodocel Colômbia, Peru
Onkotaxel Austria, Colômbia
Ribodocel Alemanha
Santax Turquia
Tadocel Turquia
Taxceus Gran-bretanha
Taxotan Alemanha
Taxotere Alemanha, Arábia Saudita, Argentina, Australia, Austria, Bélgica, Canadá, Chilli, Colômbia, Croácia, Dinamarca, Egipto, Emirados Árabes Unidos, Equator, Espanha, Estados Unidos de América, Finlandia, França, Gran-bretanha, Grècia, Hungria, Irã, Islandia, Itália, Japón, Luxemburgo, Malásia, Marrocos, México, Noruega, Nova Zelândia, Países Baixos, Polonia, Portugal, Romènia, Suècia, Suicia, Tailandia, Tunísia, Turquia, Venezuela
Texot Argentina
Tolnexa Romènia
Zenotere Índia, Peru
Bibliografía   Injetável   Bibliografía : Docetaxel  
Tipo Publicação
140 Jornal Pearson SD, Trissel LA.
Leaching of diethylhexyl phthalate from polyvinyl chloride containers by selected drugs and formulation components.
Am J Hosp Pharm 1993 ; 50: 1405-1409.
250 Jornal Mazzo DJ, Nguyen-Huu JJ, Pagniez S, Denis P.
Compatibility of docetaxel and paclitaxel in intravenous solutions with polyvinyl chloride infusion materials.
Am J Health-Syst Pharm 1997 ; 54: 566-569.
251 Jornal Trissel LA, Gilbert DL, Martinez JF.
Compatibility of doxorubicin hydrochloride liposome injection with selected other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 2708-2713.
1423 Jornal Trissel LA, Martinez JF, Gilbert DL.
Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 514-518.
1660 Jornal Thiesen J, Krämer I.
Physico-chemical stability of docetaxel premix solution and docetaxel infusion solutions in PVC bags and polyolefine containers.
Pharm World Sci 1999 ; 21: 137-141.
1662 Jornal Trissel LA, Saenz CA, Ingram DS, Ogundele AB.
Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs.
J Oncol Pharm Practice 2002 ; 8: 33-37.
1754 Jornal Trissel LA, Gilbert DL, Wolkin AC.
Compatibility of docetaxel with selected drugs during simulated Y-site administration.
Int J Pharm Compound 1999 ; 3: 241-244.
1940 Jornal Xu QA, Trissel LA.
Stability of palonosetron hydrochloride with paclitaxel and docetaxel during simulated Y-site administration.
Am J Health-Syst Pharm 2004 ; 61: 1596-1598.
1953 Jornal Trissel LA, Saenz CA, Ogundele AB, Ingram DS.
Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2004 ; 61: 2289-2293.
1982 Jornal Trissel LA, Ogundele AB.
Compatibility of anidulafungin with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2005 ; 62: 834-837.
2175 Jornal Dalle M, Sautou-Miranda V, Balayssac D, Bourlon S, Bagel S, Chopineau J.
Peut-on conditionner les solutions de docétaxel dans des poches en PVC ?
J Pharm Clin 2006 ; 25, 3: 147-152.
2210 Jornal Walker S.E, Charbonneau F, Law S.
Stability of Docetaxel Solution after Dilution in Ethanol and Storage in Vials and after Dilution in Normal Saline and Storage in Bags.
Can J Hosp Pharm 2007 ; 60, 4: 231-237.
2262 Jornal Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D.
Compatibility of doripenem with other drugs during simulated Y-site administratioN
Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
2341 Poster Bourlon S, Sautou-Miranda V, Dalle M.
Release of di(2-ethylhexyl)phtalate from polyvinylchloride bags during docetaxel infusions
Poster ESCP Stockholm May 2005
3130 Laboratório Docétaxel (Taxotere®) – Résumé des caractéristiques du produits
Sanofi Avantis France 2009
3163 Jornal Acott SR, Hart M.
Physical and chemical stability of Taxotere 1-vial 20mg/mL infusion solution following refrigerated storage.
EJHP 2010 ; 16, 5: 26-28.
3195 Jornal MacLeod S, Sewell G.
Physical and chemical stability of docetaxel infusions.
EJHP 2011 ; 17, 2: 39-43.
3215 Jornal Hart MC, Ahmed W.
Taxotere 1-vial (docetaxel 20 mg/ml) physical and chemical stability over 28 days in infusion bags containing 0.9% saline solution and 5% glucose solution.
EJOP 2011 ; 5,1: 24-27.
3277 Jornal Yang Z, Cameron S, Paul H.
Stability of Carboplatin, Paclitaxel, and Docetaxel with Acetyl-L-carnitine During Simulated Y-site Administration.
Int J Pharm Compound 2012 ; 16, 1 : 82-85.
3804 Jornal Lazzarini R, Salvadori S, Trapella C, Guerrini R, Marzola E, Pasini G, Dalpiaz A.
Physicochemical stability of cabazitaxel and docetaxel solutions.
EJHP 2014 ;22:150-155.
3937 Jornal Park K.H, Chung D.J.
Stability study of docetaxel solution (0.9% saline) using Non-PVC and PVC tubes for intravenous administration.
Biomat Res 2015 ; 19, 2

  Mentions Légales